Leading science, pioneering therapies

CRM Publications

Found 509 results
Filters: Keyword is Humans  [Clear All Filters]
2013
Stoffels JMJ, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, ffrench-Constant C, Franklin RJM et al..  2013.  Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.Brain. 136(Pt 1):116-31.
O'Carroll D, Schaefer A.  2013.  General principals of miRNA biogenesis and regulation in the brain.Neuropsychopharmacology. 38(1):39-54.
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.Genes Dev. 27(9):1032-45.
Carén H, Pollard SM, Beck S.  2013.  The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.Mol Aspects Med. 34(4):849-62.
Höiom V, Edsgärd D, Helgadottir H, Eriksson H, All-Ericsson C, Tuominen R, Ivanova I, Lundeberg J, Emanuelsson O, Hansson J.  2013.  Hereditary uveal melanoma: a report of a germline mutation in BAP1.Genes Chromosomes Cancer. 52(4):378-84.
Zhou X, Smith AG, Waterhouse A, Blin G, Malaguti M, Lin C-Y, Osorno R, Chambers I, Lowell S.  2013.  Hes1 desynchronizes differentiation of pluripotent cells by modulating STAT3 activity.Stem Cells. 31(8):1511-22.
Zheng B, Li G, Chen WCW, Deasy BM, Pollett JB, Sun B, Drowley L, Gharaibeh B, Usas A, Péault B et al..  2013.  Human myogenic endothelial cells exhibit chondrogenic and osteogenic potentials at the clonal level.J Orthop Res. 31(7):1089-95.
Chen C-W, Okada M, Proto JD, Gao X, Sekiya N, Beckman SA, Corselli M, Crisan M, Saparov A, Tobita K et al..  2013.  Human pericytes for ischemic heart repair.Stem Cells. 31(2):305-16.
Askarinam A, James AW, Zara JN, Goyal R, Corselli M, Pan A, Liang P, Chang L, Rackohn T, Stoker D et al..  2013.  Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein.Tissue Eng Part A. 19(11-12):1386-97.
Gupta K, Chandran S, Hardingham GE.  2013.  Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration.Br J Clin Pharmacol. 75(4):907-18.
Yuen TJ, Johnson KR, Miron VE, Zhao C, Quandt J, Harrisingh MC, Swire M, Williams AC, McFarland HF, Franklin RJM et al..  2013.  Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.Brain. 136(Pt 4):1035-47.
Corselli M, Crisan M, Murray IR, West CC, Scholes J, Codrea F, Khan N, Péault B.  2013.  Identification of perivascular mesenchymal stromal/stem cells by flow cytometry.Cytometry A. 83(8):714-20.
Pollard SM.  2013.  In vitro expansion of fetal neural progenitors as adherent cell lines.Methods Mol Biol. 1059:13-24.
Czopka T, ffrench-Constant C, Lyons DA.  2013.  Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.Dev Cell. 25(6):599-609.
Mackinnon AC, Liu X, Hadoke PWF, Miller MR, Newby DE, Sethi T.  2013.  Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.Glycobiology. 23(6):654-63.
Boyd A, Zhang H, Williams AC.  2013.  Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.Acta Neuropathol. 125(6):841-59.
Tura O, Skinner EM, Barclay GR, Samuel K, Gallagher RCJ, Brittan M, Hadoke PWF, Newby DE, Turner ML, Mills NL.  2013.  Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow.Stem Cells. 31(2):338-48.
Palakkan AA, Hay DC, Kumar PRAnil, Kumary TV, Ross JA.  2013.  Liver tissue engineering and cell sources: issues and challenges.Liver Int. 33(5):666-76.
Miron VE, Boyd A, Zhao J-W, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams AC, Franklin RJM et al..  2013.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.Nat Neurosci. 16(9):1211-8.
Gupta K, Hardingham GE, Chandran S.  2013.  NMDA receptor-dependent glutamate excitotoxicity in human embryonic stem cell-derived neurons.Neurosci Lett. 543:95-100.
Corselli M, Chin CJia, Parekh C, Sahaghian A, Wang W, Ge S, Evseenko D, Wang X, Montelatici E, Lazzari L et al..  2013.  Perivascular support of human hematopoietic stem/progenitor cells.Blood. 121(15):2891-901.
Szkolnicka D, Zhou W, Lucendo-Villarin B, Hay DC.  2013.  Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacology.Annu Rev Pharmacol Toxicol. 53:147-59.
Ivanovs A, Rybtsov S, Anderson RA, Turner ML, Medvinsky AL.  2013.  Postmenstrual gestational age should be used with care in studies of early human hematopoietic development.Blood. 121(15):3051-2.
Foley PL, Vesterinen HM, Laird BJ, Sena ES, Colvin LA, Chandran S, Macleod MR, Fallon MT.  2013.  Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis.Pain. 154(5):632-42.
Karwacki-Neisius V, Göke J, Osorno R, Halbritter F, Ng JHui, Weiße AY, Wong F, Gagliardi A, Mullin NP, Festuccia N et al..  2013.  Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog.Cell Stem Cell. 12(5):531-45.

Pages